The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness.
Am J Respir Cell Mol Biol
; 65(1): 13-21, 2021 07.
Article
in English
| MEDLINE | ID: covidwho-1166652
ABSTRACT
Coronavirus disease (COVID-19), the clinical syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently a global health pandemic with substantial morbidity and mortality. COVID-19 has cast a shadow on nearly every aspect of society, straining health systems and economies across the world. Although it is widely accepted that a close relationship exists between obesity, cardiovascular disease, and metabolic disorders on infection, we are only beginning to understand ways in which the immunological sequelae of obesity functions as a predisposing factor related to poor clinical outcomes in COVID-19. As both the innate and adaptive immune systems are each primed by obesity, the alteration of key pathways results in both an immunosuppressed and hyperinflammatory state. The present review will discuss the cellular and molecular immunology of obesity in the context of its role as a risk factor for severe COVID-19, discuss the role of cytokine storm, and draw parallels to prior viral epidemics such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and 2009 H1N1.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cardiovascular Diseases
/
Cytokine Release Syndrome
/
SARS-CoV-2
/
COVID-19
/
Obesity
Type of study:
Etiology study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Am J Respir Cell Mol Biol
Journal subject:
Molecular Biology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS